London’s £10bn data centre boom accelerates amid AI power crunch November 7, 2025 London’s data centre sector is entering a new phase of expansion, with three major schemes worth over £10bn revealed in the past week. The projects, all located in and around the capital, aim to serve the growing computing needs of the City, tech firms, and the broader UK economy, particularly AI workloads. The developments are [...]
Skybus steps in to save Cornwall-London route after Eastern Airways collapse November 7, 2025 Cornwall Council has struck an interim deal with airline Skybus to restore a flight route between Cornwall and London, after previous provider Eastern Airways went into administration. The new service is expected to start from late November, with 70-seat planes running daily and ultimately ramping up to twice-daily on week days by February of next [...]
UK house prices rise at fastest rate since January November 7, 2025 UK house prices edged higher in October, rising at the fastest pace since January as buyer demand remained high despite market uncertainty. Prices increased by 0.6 per cent last month, marking the fourth time in five months the average price has increased, following a sharp 0.3 per cent drop in September, according to the latest [...]
Rightmove shares in £1bn crash as AI plans spook investors November 7, 2025 Shares in Rightmove nosedived on Friday morning after the property titan revealed a major-shakeup centred on upping AI spending. The group said it would invest £60m over the next three years, with a focus on leaning into new tech. The FTSE 100 firm slashed its short-term profitability targets amid the new plans. Company boss Johan [...]
Adair Turner: Crypto? It’s like buying tulips in 1635 November 7, 2025 As chair of the FSA at the height of the 2008 financial crisis, Adair Turner knows all about the anatomy of a global crash. Over 15 years on, exuberance in AI and opaque private credit markets have set warning systems flashing. Ali Lyon, spoke to the arch-technocrat to see whether the fears are justified, and [...]
Sky in talks to buy ITV’s broadcasting arm for £1.6bn November 7, 2025 ITV has confirmed it is in early talks with Sky over the possible sale of its media and entertainment division, in a move that could reshape the UK television industry. In a statement to the market on Friday, ITV announced that it was in “preliminary discussions” regarding a potential sale of its broadcasting and streaming [...]
Reeves has learned nothing from her last Budget November 7, 2025 Amidst market uncertainty caused by her delayed and vague budget “context” speech, Chancellor Rachel Reeves is now expected to introduce a raft of significant tax increases on income, property, and businesses to address a national debt she helped exacerbate, says Jamila Robertson This week, Chancellor Rachel Reeves delivered a speech to set the context for [...]
If Reeves can’t cut tax, she could at least make it more competitive November 7, 2025 The UK ranks 32 out of 38 OECD countries for tax competitiveness. Reeves must not make it worse at the upcoming Budget, says Sophie Dworetzsky As the forthcoming Budget is less than a month away, speculation as to what personal tax changes – and rises – it may bring, is becoming ever more intense. With [...]
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights November 6, 2025 Net cash used in operating and investing activities was $40.6 million and $140.4 million for the third quarter and first nine months of 2025, respectively; quarter-end cash and restricted cash position was $331.7 million Roche to initiate the Phase 3 PARAISO clinical trial evaluating prasinezumab, a potential first-in-class anti-alpha-synuclein antibody, for early-stage Parkinson's disease by end of 2025 Novo Nordisk initiated the Phase 3 CLEOPATTRA clinical trial evaluating coramitug, a potential first-in-class amyloid depleter, for ATTR amyloidosis with cardiomyopathy Novo Nordisk to present Phase 2 results for coramitug during a late-breaking session at the American Heart Association Scientific Sessions on November 10, 2025 Bristol Myers Squibb obtained Fast Track designation from the U.S. FDA for BMS-986446 (PRX005), an anti-MTBR-tau-targeting antibody, for the treatment of Alzheimer’s disease Prothena will convene an Extraordinary General Meeting on November 19, 2025 to obtain shareholder approval on a proposal reducing share capital to create distributable reserves to support a share redemption program to be conducted in 2026 if deemed appropriate Potential to earn up to $105 million in aggregate clinical milestone payments by end of 2026 related to the advancement of coramitug for ATTR amyloidosis with cardiomyopathy by Novo Nordisk and PRX019 for neurodegenerative diseases by Bristol Myers Squibb
Now is the perfect time to visit Tbilisi Georgia – here’s what to see and where to stay November 6, 2025 A destination hotel occupying a stately Brutalist building is one of a few things making Tbilisi Georgia unmissable, says Kamila Erkaboyeva There’s long been a whisper on the street that Tbilisi is Europe’s coolest capital, but without direct flights from the UK, it’s been out of reach for a long weekend. Thankfully, British Airways launched [...]